Regina Hourigan,Jeffrey Mastrull,Jairajh Mattai,James Masters
申请号：
US14362903
公开号：
US09414587B2
申请日:
2011.12.15
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol and a sorbitan ester. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators. If isopropyl is selected, then the sorbitan ester is at least one of polyoxyethylene 20 sorbitan monooleate, and a proviso that if isobutyl magnolol is selected, then the sorbitan ester is poloxyethylene 20 sorbitan monooleate.
